
Sign up to save your podcasts
Or


Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303452
By Michael Putman4.9
114114 ratings
Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303452

503 Listeners

296 Listeners

129 Listeners

3,368 Listeners

1,147 Listeners

119 Listeners

194 Listeners

519 Listeners

67 Listeners

4 Listeners

375 Listeners

183 Listeners

186 Listeners

19 Listeners

6 Listeners